Related Experiment Videos
Fluvastatin with and without niacin for hypercholesterolemia
T A Jacobson1, M M Chin, G J Fromell
1Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303.
The American Journal of Cardiology
|July 15, 1994
Summary
Fluvastatin effectively lowers LDL cholesterol and improves HDL cholesterol and triglycerides. Combining fluvastatin with niacin further enhances lipid profile improvements with good tolerability.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypercholesterolemia poses a significant risk for cardiovascular disease.
- Dietary interventions alone are often insufficient for achieving lipid-lowering goals.
Purpose of the Study:
- To evaluate the efficacy and safety of fluvastatin monotherapy and its combination with niacin in patients with hypercholesterolemia.
- To assess the impact on low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride levels.
Main Methods:
- A randomized, double-blind study involving 74 patients with elevated LDL-C.
- Patients received fluvastatin (20 mg/day) or placebo for 6 weeks, followed by the addition of niacin (up to 3 g/day) for 9 weeks.
Main Results:
- Fluvastatin monotherapy reduced LDL-C by 21% (p < 0.001).
- The combination of fluvastatin and niacin achieved a 40% reduction in LDL-C compared to 25% with niacin alone (p < 0.001).
- Both treatments significantly improved HDL-C (approx. 30% increase) and triglycerides (approx. 28% decrease).
- Fluvastatin-niacin combination led to a 37% decrease in Lipoprotein(a).
- The treatments were well-tolerated with no serious adverse events or myositis observed.
Conclusions:
- Fluvastatin, as monotherapy and in combination with niacin, is an effective and safe treatment for hypercholesterolemia.
- The combination therapy offers potentiated lipid-lowering benefits.
- Further long-term safety monitoring is recommended for the fluvastatin-niacin combination.